The FDA Just Approved a Radical Technology Set to Save over 2 Million Lives Called...
It's giving "superhuman" healing powers to American soldiers… dying cancer patients... even infants…
It's increasing their chances of survival by over 95%...
And by December 31, the FDA is expected to make it the standard of care – with one tiny $6 firm holding the only FDA-approved patent.
While on patrol in Kandahar, Afghanistan, First Lieutenant Joshua Jones's Humvee rolled over an IED buried in the dusty road.
The explosion transformed his vehicle into a "twisted inferno."
And while he was able to heroically escape the wreckage, First Lieutenant Jones was massively bleeding out from his right arm and left leg.
His blood pressure dropped to a shocking 99/41; his pulse was over 156 beats per minute; and his body was seconds away from going into shock.
If First Lieutenant Jones didn't receive treatment soon, he was going to die.
Army medics rushed in. They applied tourniquets on his arm and leg and compression dressings on his wounds.
But it wasn't enough. So the medics brought out the army's latest breakthrough in medical technology.
They immediately issued 20 units of the cryogenic blood. Then, something amazing happened.
Even though First Lieutenant Jones was seconds away from death, his body began to miraculously repair itself.
The piercing wounds… the lacerations caused by exploding shards of metal… all the damage caused by the IED began healing at a "superhuman" rate.
It was as if time was sped up, and First Lieutenant Jones's body began healing at hyperspeed.
It Was as If He Spent Six Weeks in a Hospital in under Five Minutes.
His wounds began closing all on their own – without any need for intensive surgery.
First Lieutenant Jones was then transported to a hospital. His injuries healed, and he was later discharged, returning home an American hero.
It sounds like something straight out of a Hollywood movie. But it's not.
First Lieutenant Jones Was a Part of a Little-Known Government Program Started by DARPA in 2012.
The program was the culmination of over 70 years of scientific research that involved hundreds of America's top scientists from Harvard, Stanford, and Yale developing this radical technology called cryogenic blood.
And with part of the United States' $290 billion medical budget supporting it, the cryogenic blood program could completely revolutionize medicine and save over two million people's lives.
And the program was a resounding success.
Cryogenic blood could begin healing any traumatic injury within seconds.
Whether they are injuries from an exploding IED…
Or from a 12-hour-long brain surgery…
Or from poisonous chemotherapy treatments…
Cryogenic blood can be used to dramatically reduce the damage and save people's lives.
And one recent study showed that cryogenic blood's key ingredient gives people over a 95% survival rate.
That's Right. A 95% Survival Rate.
And I'm here to tell you about how it could change your life too.
Hello, my name is Michael Robinson.
I am a 35-year Silicon Valley veteran and the director of technology and venture capital research for Money Morning, a large financial publisher located in Baltimore, Maryland.
And thanks to this technology I call cryogenic blood, First Lieutenant Jones is just one of a growing number of success stories.
Like nine-month-old Jessica from New York, who one day suffered a severe injury as the result of a horrific fall.
Baby Jessica was bleeding from her leg and it wouldn't stop.
Her parents tried bandages, wrappings, gauze – everything to stop the bleeding. But nothing worked.
Baby Jessica was losing blood fast and was rushed to the emergency room...
Where they discovered she had a rare, potentially fatal blood disorder…
That if left untreated would kill her.
Quickly, the doctors gave her a single injection of cryogenic blood.
The cryogenic blood contained special properties that allowed baby Jessica's body to radically heal itself.
And for the first time in her life, her body was able to stop the massive bleeding.
She went from dying on the table to living a completely normal life.
Now her condition is no more difficult to treat than diabetes or high blood pressure.
And that's not all cryogenic blood can do…
"Cryogenic Blood" Can Even Help Cure Cancer.
At 58 years old, just two weeks after the birth of her second grandchild, Sandra Comings received the worst news of her life.
Sandra had leukemia.
And not just any form of leukemia. She had the most dangerous subtype called acute myeloid leukemia. She needed immediate treatment.
Along with standard chemotherapy, Sandra received several treatments of cryogenic blood.
Without cryogenic blood, Sandra risked massive bleeding in her brain and lungs.
But thanks to cryogenic blood, Sandra's body was able to repair the horrific damage caused by chemotherapy and stop her brain and lungs from hemorrhaging.
After a Few More Treatments of Cryogenic Blood, Sandra was Cancer-Free.
Sandra's story is being repeated again and again across the country.
Any time a cancer patient has surgery or receives an invasive treatment, they risk massive trauma and bleeding.
But cryogenic blood could become the new standard of care for any cancer patient receiving chemotherapy treatments.
In fact, there are already three different variations of cryogenic blood in production, each with its own specific use.
And with 1.7 million new cases of cancer in the U.S. every year – cryogenic blood could save millions of lives.
Lieutenant Jones's, Jessica's, and Sandra's stories are just the tip of the iceberg.
The National Institutes of Health currently lists 9,432 clinical trials for cryogenic blood's key ingredient being conducted by universities like…
- Mayo Clinic…
- Cleveland Clinic…
- And more.
And they have led to some stunning discoveries.
Discoveries that could forever change the way we treat injuries.
The three different types of cryogenic blood can regenerate and repair any piercing, laceration, or severe injury almost instantly – without dangerous side effects.
And patients never develop a resistance or tolerance to it.
Which is why by December 31, the FDA is expected to release a new guidance document dictating a new standard of care for cryogenic blood technology throughout the country.
It's already changing the lives of U.S. soldiers and other people suffering from life-threatening diseases.
Today, I'm going to show you how it can change your life too.
Over the course of my 35-year career, I've been a board member of one venture capital firm and a senior advisor for two more.
And mark my words: Cryogenic blood will be the most disruptive medical technology we'll see this decade.
In fact, I believe that every medical system on the planet will try desperately to get their hands on as much of this miracle blood as they can.
The U.S. military has already put $201 million into this technology.
The FDA is expected to release guidelines later this year that could make cryogenic blood the new standard of care for traumatic injuries in hospitals across the United States.
This would make it completely mandatory for cryogenic blood to be in every hospital, ambulance, trauma center, emergency room, and operating room across the United States.
In a few short months, all 6,210 hospitals in the United States could have access to cryogenic blood technology.
This is one of the most exciting opportunities in medical science since the discovery of antibiotics.
And it's one of the most exciting investment opportunities as well.
You see, one company is at the center of it all.
In 2014, they received FDA approval to produce a specialized cryogenic blood that only they can make.
Once the FDA approves cryogenic blood as the new standard of care by December 31, they will be set for complete domination.
That's Why Experts Call This Company "Essentially the Only Player in This Market."
They also recently received a massive order from Germany for 580,000 units of their cryogenic blood.
And France just adopted it as the standard of care throughout the entire country.
And with their new cryogenic blood, this company's revenues could skyrocket exponentially from its current $64 million.
When that happens, many everyday Americans could become millionaires from this tiny company.
And today, I'm offering you the chance to be one of them.
I'll tell you more about how you can take advantage of this amazing opportunity in a moment, including a stock projection that will blow you away.
But first, let me explain the science behind this miraculous blood and why it's changing nearly everything about modern medicine.
As I mentioned before, scientists have developed three different types of cryogenic blood.
One is a frozen, concentrated version. One is based on the platelets in blood. And one is based on blood plasma.
And they all give you superhuman healing abilities.
And by superhuman, I literally mean "beyond human."
This is because all types of cryogenic blood are able to take your body's natural healing mechanisms and supercharge them to levels your body normally cannot do by itself.
Let me use the example of First Lieutenant Jones from before.
First Lieutenant Jones suffered major injuries from an exploding IED.
He was experiencing massive bleeding from his arm and leg.
His pulse was weakening, and he was going into what's called hypovolemic shock.
Hypovolemic shock is when you lose more than 40% of your blood volume.
Your blood pressure drops, and you start losing consciousness. You risk brain damage, organ failure, and ultimately death.
Now, to prevent that from happening, your body produces blood-clotting proteins called fibrin and platelets to stop the bleeding.
But if you lose too much blood, like First Lieutenant Jones, your body cannot produce enough blood-clotting proteins to stop the bleeding.
This is where cryogenic blood comes in.
Cryogenic blood has special healing properties that allow your body to dramatically increase the amount of blood-clotting proteins in your body.
It's almost like adding a turbocharger to your car.
A turbocharger adds extra energy and power to your car's engine that it wouldn't have otherwise.
That's exactly what cryogenic blood is doing.
It enters your body and provides a boost to your body's natural healing processes.
Your number of blood-clotting proteins dramatically increases – and your body is able to heal itself at a superhuman rate it cannot do on its own.
So whenever a U.S. soldier is dying out on the battlefield… or a small child is suffering from damaging cancer treatments… you just inject a few units of cryogenic blood...
And their body is able to repair the damage and potentially save their life.
One Recent Study Showed That Cryogenic Blood Has a 95% Success Rate.
With a 95% success rate, cryogenic blood can be much more effective than dangerous prescription drugs or intense surgery.
You are simply boosting your body's own natural healing powers. Giving yourself superhuman healing capabilities.
And the best thing about cryogenic blood is that it replaces the messy and dangerous business of full-body blood transfusions.
Before cryogenic blood, if you were suffering from massive bleeding, your best and only option was a full-body blood transfusion.
But there are a lot of problems with full-body blood transfusions.
- You need a lot of blood of a compatible blood type.
- Since it's just normal blood, you don't have any increased healing ability.
- You risk deadly blood infections such as sepsis.
Cryogenic blood solves all three of those problems.
First, cryogenic blood is cross-compatible, meaning it doesn't matter what your blood type is.
Second, cryogenic blood has superhuman healing abilities, so you need considerably less of it for it to work.
And last, this tiny, California-based company has developed a way to practically eliminate deadly infections from blood transfusions.
This is huge because death from blood infections has become a major problem in the past few years.
For example, recently a Utah man named John made headlines when he died from a blood transfusion gone wrong.
John was suffering from leukemia and went in for a routine blood transfusion.
Thirty minutes later, John started shivering uncontrollably. The doctors tested his blood and found the deadly bacteria C. perfringens.
Four days later, John was dead.
Similar stories have been repeated all across the United States. People have died from blood transfusions gone wrong.
But This $6 Company from California Is About to Change All of That.
Not only is it a producer of this new superhuman cryogenic blood… but it is the only company with an FDA-approved process for making it 100% immune to deadly pathogens.
That means it is the only company with practically 100%-safe cryogenic blood.
That's why experts call this company "essentially the only player in this market."
And the world is already taking notice.
In fact, by December 31, cryogenic blood is expected to become the new standard of care in the United States. Twenty of some of the nation's largest blood-processing plants are expected to get approval to produce cryogenic blood on a truly massive scale.
The amount of profits this $6 firm will generate could be enormous. Just look at what happened with previous pharmaceutical companies in the past.
Pfizer saw its stock price soar a total of 9,650% due in part to the approval of Lipitor in 1996.
And get this. Pfizer has just nine manufacturing sites.
Compare that to the 20 manufacturing sites this company's cryogenic blood is expected to have.
It's not crazy to think this $6 stock could explode 10,000% or more.
Let me show you another example.
This time it's Gilead Sciences, the maker of the hepatitis drug Ledipasvir.
Due in part to the approval of Ledipasvir in 2014, Gilead's stock shot up over 21,526%.
And they have just four manufacturing plants.
Not 20. Just four.
Or take GlaxoSmithKline, the maker of asthma-drug Advair.
Their stock shot up 12,372% due in part to the approval of Advair.
And they only have nine manufacturing sites. Not 20.
Same thing with Bristol-Myers Squibb's heart-attack drug Plavix.
Their shares shot up over 8,146% due in part to the approval of Plavix in 1998.
Are these rare and exceptional gains? You bet, and they do not happen every day.
But just imagine how much more profitable investing in this small company could be.
And these companies are operating at just a fraction of the expected capacity of the cryogenic blood-processing plants.
Mark your calendar for December 31.
By December 31 of this year, we expect to see a sea change in how traumatic injuries are treated in this country. And soon throughout the entire world.
Cryogenic blood could enter into mass production on a scale never before seen.
Every hospital, operating room, ambulance, trauma center, and ICU in 20 of the largest blood-processing sites across the country could be equipped with this lifesaving technology.
It won't be long before every country in the world with advanced medical systems adopts this technology.
And this tiny $6 company has the only fully patented, FDA-approved, pathogen-free product on the market.
I fully expect this stock to shoot up 10,000% or more based on what's happened in this industry in the past.
Granted, I don't have a crystal ball to perfectly predict the future. And I don't recommend that you bet more than you can afford to lose on any one stock.
Investing involves risk, including risk of loss. But there is no denying that come December 31, this small company's stock price could go ballistic, and you could profit tremendously from this action.
And now could be your best chance to get a piece of that action.
I believe this stock won't stay $6 for long.
When you think about the number of lives being saved by this breakthrough, it's just astounding. This is every bit as big as the discovery of penicillin.
Cryogenic Blood Could Save over 800 Children per Day from Dying.
Traumatic injury is one of the leading causes of death among children.
Whether it's from car accidents, falling from heights, or many other heartbreaking incidents, over 2,000 children die every day from trauma.
Now, some of those deaths include things like poisoning and drowning, where there is no chance of survival.
But an estimated 40% of those deaths could easily be prevented with a simple injection of cryogenic blood by an EMT.
That means with cryogenic blood, over 800 child deaths per day could become a thing of the past.
That's over 5,600 children per week, 24,000 children per month, or 292,000 children per year saved by cryogenic blood.
And if you include adults, that number goes from 292,000 to two million.
That's Right. Two Million Lives Saved per Year.
It's no secret why the FDA gave its "Breakthrough Device Designation" to this $6 firm's cryogenic blood technology.
If you're not familiar with the FDA's Breakthrough Device Designation – it's an amazing program.
The Breakthrough Device Designation allows companies to dramatically speed up the approval process for lifesaving technologies.
But not every company can get one of these designations – it's only reserved for the best of the best.
This $6 firm already has two cryogenic blood technologies on the market, and with the third one receiving this breakthrough device designation, this firm is set for total domination.
Like I said: by December 31, this company's product is expected to become the standard of care throughout the country.
They will have 20 manufacturing sites serving areas across the entire nation.
Compare that to Pfizer's nine.
Or Gilead's four.
Or GlaxoSmithKline's nine.
We're about to see a scale of production rarely seen in the medical world.
This can be the ground floor of something huge.
I believe this $6 company could easily have over a 10,000% surge in the next several years.
That's right around where Pfizer, Gilead, and GlaxoSmithKline saw their gains.
That would be like $2,000 turning into $200,000.
Moments like these are rare and extraordinary, but they do happen.
All you need is the right technology in the right place at the right time.
And I believe cryogenic blood could lead the next medical revolution.
Which is why I've prepared an exclusive dossier that will give you all the details on the tiny $6 company that could have an explosive 10,000% price surge.
It's titled The $6 Company Riding the Cryogenic Blood Revolution.
This dossier can be yours absolutely free.
Of course, because of the nature of this opportunity and because this $6 company is tiny…
I need to restrict the circulation of this dossier.
I've authorized a limited release today of 477 copies.
And once they're gone, they're gone.
And I want to send it to you immediately after this presentation because we don't have much time to waste.
It will first introduce you to this firm's executive team.
From an investment standpoint, this is easily one of its biggest selling points.
Their co-founder and chief scientific officer was a lead consultant to the FDA Advisory Panel and serves on the U.S. government's Health and Human Services' Advisory Committee.
Their chief medical officer served as the CMO for the American Red Cross – which oversees 40% of the United States' blood supply. He was also a medical director at Harvard.
Their senior VP also served as the senior vice president for 11 years at the American Red Cross.
The FDA… the U.S. government… the American Red Cross… this firm's executive team has inside connections to make cryogenic blood a massive success.
And with the mass production of cryogenic blood expected to come, there's no time to waste.
It's all inside your free report – The $6 Company Riding the Cryogenic Blood Revolution.
It's yours when you accept a risk-free invitation to join...
As I mentioned, I've been a board member of one Silicon Valley venture capital firm and a senior advisor to two more.
In the 1980s, I worked alongside Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, respectively, as they led the robotics revolution that saved the U.S. automotive industry.
In the '90s, I was one of five people in the early meetings for the $160 billion "cloud-computing" phenomenon.
And after the millennium, as cyber security was becoming a focus for the U.S. Intelligence Community, I was with Dave DeWalt, the CEO of McAfee...
Right before Intel acquired his company for $7.8 billion.
Today, I put my decades of experience and connections to work for members of the Nova-X Report.
Through the Nova-X Report, I bring you into my world.
I show you how to get involved with the world's most disruptive technologies as they're being developed.
And I'm going to show you how you can claim the financial windfalls typically available only to early investors.
For example, I recently showed my readers a once-in-a-lifetime opportunity to "partner" alongside one of Silicon Valley's top venture capitalists.
This was a guy who had made billions from some of the biggest IPOs of the decade, including Twitter, LifeLock, and FireEye…
And through his VC firm, my readers had a chance to grab stakes in 30 of the most exciting privately held companies in America about to IPO.
I'm talking about multibillion-dollar companies like Lyft, Spotify, DocuSign, Hightail, Tintri, and Cloudera – all with the potential to pay off in huge multiples, 200-fold or better.
Of course, if you're not a hedge-fund manager or VC billionaire – you normally have no chance at private deals like these.
But my readers had a chance to take advantage of this opportunity with special terms.
This is what all my publications – including Nova-X Report – are all about.
Giving you a once-in-a-lifetime chance to invest in potentially the most lucrative ground-floor opportunities you'd never get a shot at anywhere else.
Every month, I'm going to vet and present you with a new opportunity.
You will receive it in a comprehensive research dossier.
It will dissect the company's technology and where it fits in the market.
You will be "introduced" to the scientists and engineers behind it.
And it will walk you through exactly what kind of impact this technology could have on the world.
We will closely examine their books, revenue streams, and profit projections.
And if everything lines up right – I'll show you exactly how to position yourself to capture the historic gains each opportunity presents.
As the director of technology and venture capital research, it's this approach that has allowed me and my team at Money Morning to deliver a nonstop series of enormous windfalls.
So, when you come aboard as a member of the Nova-X Report, you'll not only get my urgent cryogenic blood briefing…
You'll also get these three Special Bonus Reports…
BONUS REPORT #1: The $12.3 Billion Medical Tech Play That Could Make You Millions
The billions of dollars coming in and out of our health-care system is staggering.
And there is nothing I like more than what can be a "guaranteed money" investment.
By "guaranteed money," I mean companies who provide a service for a system everyone has to use.
Like companies who process credit card payments for banks. Every time a credit card is used, they get "guaranteed money" from the bank for the transaction.
Well, I found a $12.3 billion medical tech play that's similar.
This company's sole purpose is to collect guaranteed money from over 170 health-insurance companies every time people use their service to sign up for insurance.
They are simply a middleman for processing the transactions.
And this all amounts to a staggering $12.3 billion payday per year.
This firm's revenue is already up 60% last quarter and is climbing quickly.
You'll want to consider taking action fast on this one.
BONUS REPORT #2: The Silicon Valley Firm at the Center of the $55 Billion Automation Revolution
Automation is coming to nearly every corner of American business.
But perhaps where it is happening most is in hospitals.
In fact, the medical-automation market is projected to be worth $55 billion by 2020.
And I've discovered one firm that could make an absolute killing.
They use artificial intelligence, the cloud, and robotics to help drive down health costs and improve patient safety.
Their systems manage hospital inventory… package and dispense prescription drugs… and even help prevent theft of highly addictive medications.
They already could make over $1 billion in revenues… but nearly every analyst I know has them going way higher.
BONUS REPORT #3: Profiting from "Secret" Military Spending
The Pentagon's black budget – the budget they use for classified operations they keep under wraps – topped $68 billion this year.
And I'm confident that I've figured out where a big chunk of it is going...
It's going to a little-known company that makes secret communications packages and surveillance gear. They're projected to secure $5.3 billion in contracts going forward.
Contracts that should translate into gains of 260% to 370% as a reward for investing at the right time.
And as a member of Nova-X Report, you'll be on the leading edge of breaking technologies like these that will mint millionaires many times over.
In fact, every month I'll send you a streamlined Deal Briefing, where I'll recommend a company that can dominate an enormous market.
Recently, I've targeted lucrative opportunities in areas like…
Advanced military weapons, drones, quantum computers, genomics, 3D bioprinting, and deep learning – an advanced form of A.I.
As you'll discover, each Deal Briefing leaves no stone unturned…
It provides you with a streamlined analysis of the company, its executive team, proprietary technologies, revenue projections, and sources of venture capital funding.
And from time to time, I will issue Nova-X Special Reports on situations that – like cryogenic blood – demand special attention.
Take what happened in 2016…
I made an announcement that caused the heads of some folks out here in Silicon Valley to explode.
I declared that every American needs to go…
"All in on marijuana!"
I didn't care that it was illegal on a federal level. I didn't care that a lot of people saw it as taboo. None of that mattered.
This was about making money. Plain and simple.
In September of 2016, I released all my research on 30 pot stocks to Nova-X Report readers.
In the months that followed, every single one of them hit peak positive gains.
In fact, 17 soared into triple digits.
Mentor Capital shot up as much as 1,828% in less than six months.
InMed Pharmaceuticals… 617% in about four months.
CannaGrow… 456% in the same amount of time.
I was thrilled to see letters coming in from folks who followed my recommendations.
Because they had the guts to take a chance on a "controversial investment."
"I'm up $17,000 in 4 weeks!"
– Chuck Ardeen
"I made $20,000 on this trade!"
– Kristen Benjamin
"In under a month I made $44,958. I'm going to be a millionaire!"
– Rich Hoskins
And once I release a Deal Briefing or Special Report, I'm going to be "by your side" providing you with weekly Nova-X Progress Dossiers.
I'll keep you up to speed on any new developments, product launches, and earnings reports, and I'll give you a complete rundown on what we're seeing in our Model Portfolio.
Of course, when it's time to collect any profits on these deals, I'll be with you every step of the way.
When the moment arrives, you'll receive an instant Trade Alert along with my analysis.
I'll send it via email.
However, I strongly suggest you take advantage of another optional subscriber benefit…
Cell phone text message notifications.
Every time I issue a new Deal Briefing, Special Report, or Trade Alert, I'll send you a quick text message to let you know.
This will ensure you get this information as soon as possible.
For instance, with one of my picks – Micron Technology – folks following my research had the opportunity to get in and out of that trade in a day.
I actually received a letter from a doctor who told me he bought Micron while boarding a cruise and cashed out the next day for a 136% gain!
"I purchased Micron while boarding a cruise. I sold while cruising for a 136% gain. It paid for my vacation."
– Dr. Marshall Grisafi
He paid for his entire vacation with the profits…
And the lucrative cryogenic blood opportunity that I want to share with you today could help YOU pay for many future vacations too.
Now, when you become a Nova-X member, I'll also be sharing regular Video Updates with you whenever I interview the CEOs of the companies we're targeting or whenever there's an urgent update from one of our picks.
This way, you can get the real scoop straight from the source.
Your membership also includes 24/7 access to Nova-X HQ.
This exclusive website is where I store every Deal Briefing, Special Report, and Trade Alert.
So as you can see, Nova-X Report is comprehensive.
It's also HUGELY successful.
In addition to those MASSIVE pot-stock winners I showed you earlier, I've also shown readers of my services how they could collect 65 double- and triple-digit winners. Some were even partial trades!
264% from Nvidia…
213% from Broadcom…
111% from Skyworks…
116% from Activision Blizzard…
121% from Universal Display Corp…
And 112% from Shopify.
The folks in my research services who have listened to me are thrilled.
Some, like Gerard Nemus, can now look forward to retiring without a care in the world…
"You have allowed my wife and I to be worry-free about retirement... the $90,000 in one month was great too!"
– Gerard Nemus
Others, like Kevin Shannon, have been able to put their kids through college…
"I have been following you for over a year. Your insights have been right on. You have helped me fund my children's education and also helped me pay some bills!"
– Kevin Shannon
Plus, there's Mark Oswald, who was able to finally fulfill a lifelong dream…
"Thank you! I was able to buy the vehicle of my dreams – a 20ft RV! And help my children out financially..."
– Mark Oswald
But that's not all…
Ryan Jared also sent me this heartwarming message…
"Michael, I have a wife and two kids. You have helped my young family recover from the 2008 crisis where we lost everything, including our home. Thanks to you I have been able to rebuild my nest egg."
– Ryan Jared
And now, I'd like to give YOU the chance to experience similar life-changing paydays.
Starting with the ENORMOUS cryogenic blood opportunity I've been telling you about.
So claim your deal briefing immediately, and we'll get started right away.
Join Nova-X Report, and you'll get instant access to NUMEROUS money-spinning opportunities.
But while there will be a multitude of plays coming down the pike, you will NEVER have another opportunity like you have today, right now.
You see, we are at the genesis of a whole new world of medicine.
The very beginning.
And this $6 company with its FDA-approved cryogenic blood technology is expected to make it all happen…
If you're serious about the opportunity to mint yourself a fortune from this company, then you need to move FAST.
Because as of today…
I Can Only Accept 477 New Subscribers to Nova-X Report.
So if you want in, it's decision time.
Act now, or you could miss out.
It's your call.
But please understand that these spots will fill up quickly. Very quickly.
I'll rush you over your special cryogenic blood dossier immediately.
But that's not all you'll get.
You'll also receive instant access to my entire portfolio of stock recommendations.
Every one of these has the potential to deliver a big win.
And still, this is all just the beginning of what can be an ongoing profit frenzy with Nova-X Report…
You see, right now, I'm tracking new innovations and technologies that could mint millionaires in cutting-edge technologies, including…
Every month, you'll receive my Nova-X Report, which will include at least two opportunities with ultra-lucrative investment potential straight from the world of Silicon Valley.
It will also include my Nova-X Instant Trade Alerts with my research and exact recommendations and specific "buy" and "sell" instructions on every play.
Your membership also includes…
Nova-X Weekly Progress Reports with updates on our current portfolio, insights into new opportunities, and emerging trends and shifts happening in Silicon Valley…
Nova-X HQ, a password-protected website that gives you complete access to every trade recommendation, every research report, every investor video, and all my research and interviews with some of the most well-known CEOs in the world…
And the 24/7 VIP Concierge Service team so you can talk to a real, live person anytime you need help with your subscription.
Plus, I am going to send you my four Special Briefings immediately when you come aboard...
The $6 Company Riding the Cryogenic Blood Revolution
The $12.3 Billion Medical Tech Play That Could Make You Millions
The Silicon Valley Firm at the Center of the $55 Billion Automation Revolution
Profiting from "Secret" Military Spending
As you can see, we've pulled out all the stops.
We're doing everything we can to help you have a shot at creating the kind of wealth that lasts generations.
The Nova-X Report gives you direct access to the biggest, potentially most lucrative, and fastest-moving technology opportunities that could make you extremely wealthy.
Which is why it's not inexpensive to join.
Our normal price is $299 a year.
That's a fair price for everything you're getting.
However, today through this special offer, you won't pay anywhere near that.
Forget 50%... or 60%... or 70%... or even 80% off...
If you join the Nova-X Report today, you get the research service for the unbelievable price of just $39.
This is a deal too good to pass up.
You have to click the button below to get the details.
When you do, you'll also discover that your membership is protected by not one but two 100% money-back guarantees. So there's no risk to you for joining.
What are you waiting for?
The cryogenic blood revolution is taking flight before your very eyes.
It's happening right now as you read this.
And I want you to have a chance to make a ton of money from it.
This $6 company could make you rich beyond your wildest dreams.
But to find out its name and what you need to do to take advantage of the opportunity, you need to claim your special deal briefings immediately.
Remember, there are only 477 available today, and it's strictly first come, first served.
I'm certain they'll be snapped up in no time at all.
Cryogenic blood is the greatest breakthrough of the century.
It's projected to unlock a phenomenal new world of innovation and untold wealth.
So if you want in, click the button below to become a new member of Nova-X Report while you still can.
Or miss out.
It's up to you.
If you have any questions about the service and how it will work for you, I encourage you to contact our reliable Concierge Service team at 888-384-8339 or 443-353-4519 (for international calls) and mention Priority Code: ENVXV842.
Director of Technology and Venture Capital Research, Nova-X Report
Copyright - 2019 Money Map Press, LLC. Legal Notices: In order to ensure that you are utilizing the provided information and products appropriately, please be sure to visit Money Map Press Terms and Conditions